Want to see TSE:BRM full AI Analyst Report?
BRM Stock Chart & Stats
C$3.02
-C$0.01(-0.33%)
At close: 4:00 PM EDT
C$3.02
-C$0.01(-0.33%)
Day’s Range― - ―
52-Week RangeC$1.87 - C$3.62
Previous CloseN/A
Volume9.69K
Average Volume (3M)32.44K
Market Cap
C$56.10M
Enterprise ValueC$54.18
Total Cash (Recent Filing)C$7.19M
Total Debt (Recent Filing)C$2.49M
Price to Earnings (P/E)8.9
Beta0.48
Next Earnings
Nov 24, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding16,307,028
10 Day Avg. Volume30,537
30 Day Avg. Volume32,440
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.90
Price to Sales (P/S)1.02
P/FCF Ratio5.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.3
Revenue Forecast (FY)C$47.50M
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilitySustained margin improvement to mid-teens EBIT and ~11% net indicates the business has moved to healthier unit economics. Higher operating profitability increases resilience to volatility in project timing and supports reinvestment in engineering, aftermarket services, and selective growth initiatives.
De-risked Balance SheetMaterial reduction in leverage to a low debt-to-equity ratio strengthens financial flexibility. Lower debt reduces refinancing risk, supports investment in project backlog and aftermarket capacity, and better positions the firm to weather municipal funding cycles or invest in product development.
Recurring Aftermarket + Regulatory TailwindsA project-based sales model supplemented by recurring aftermarket parts/services plus regulation-driven demand creates a durable revenue base. Aftermarket and service streams smooth cyclical new-build volatility and increase lifetime customer value, supporting steadier long-term cash generation.
Bears Say
Weak Cash GenerationAn 83% fall in free cash flow year-over-year signals working-capital swings or project timing issues that can undermine the conversion of accounting profits into spendable cash. Persistent cash volatility limits capital deployment, raises financing needs, and increases execution risk for project deliveries.
Choppy Revenue GrowthThe company shows recovery but uneven, mid-single-digit trailing growth and prior declines highlight sensitivity to capital spending cycles in municipal and industrial markets. This variability makes forecasting project backlog and margin sustainability harder over a multi-quarter horizon.
High ROE SensitivityVery high ROE reflects recent profit leverage to equity but increases sensitivity to earnings normalization. If revenue or margins revert toward historical levels, ROE and investor returns could fall sharply, revealing potential volatility in profitability metrics despite stronger balance-sheet metrics.
Biorem Inc News
BRM FAQ
What was Biorem Inc’s price range in the past 12 months?
Biorem Inc lowest stock price was C$1.87 and its highest was C$3.62 in the past 12 months.
What is Biorem Inc’s market cap?
Biorem Inc’s market cap is C$56.10M.
When is Biorem Inc’s upcoming earnings report date?
Biorem Inc’s upcoming earnings report date is Nov 24, 2026 which is in 112 days.
How were Biorem Inc’s earnings last quarter?
Biorem Inc released its earnings results on Jul 28, 2026. The company reported C$0.105 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Biorem Inc overvalued?
According to Wall Street analysts Biorem Inc’s price is currently Overvalued.
Does Biorem Inc pay dividends?
Biorem Inc does not currently pay dividends.
What is Biorem Inc’s EPS estimate?
Biorem Inc’s EPS estimate is 0.09.
How many shares outstanding does Biorem Inc have?
Biorem Inc has 16,307,028 shares outstanding.
What happened to Biorem Inc’s price movement after its last earnings report?
Biorem Inc reported an EPS of C$0.105 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 18.482%.
Which hedge fund is a major shareholder of Biorem Inc?
Currently, no hedge funds are holding shares in TSE:BRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biorem Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
31.51%
Trailing 12-Months
Company Description
Biorem Inc
BioRem Inc. is a clean technology engineering firm specializing in the development, manufacturing, and global distribution of environmental air purification systems. These systems are engineered to combat a range of airborne contaminants, including foul smells, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). Their comprehensive product line features biofilters for treating odors, hydrogen sulfide (H2S), VOCs, and HAPs, alongside biotrickling filters specifically designed for high concentrations of H2S or water-soluble VOCs. The company also supplies advanced multi-stage systems for odor removal in municipal and urban wastewater treatment facilities, biogas desulfurization systems, dry scrubber adsorption systems, and solutions for cannabis odor control. Complementing its product offerings, BioRem provides essential services such as biological process testing, media sampling and analysis, system reviews and inspections, and the provision of replacement media and spare parts. With operations spanning Canada, the United States, China, and other international regions, BioRem Inc. was founded in 1990 and is based in Puslinch, Canada.
Technical Analysis
―
Sharc International Systems Inc
―
Questor Technology
―
Thermal Energy International
―
Greenlane Renewables Inc
―